Physician profile
Tricia E Markusen
NPI 1912908955
$2,363.60
in general payments reported to CMS, 2019-2025
28 companies · $408 in 2025
The $408 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $286 · 2021: $452 · 2022: $309 · 2023: $286 · 2024: $365 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.10 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $373.62 | 2021-2025 | |
| Amgen INC. | $322.02 | 2019-2025 | Evenity, Prolia, Prolia |
| Therapeuticsmd, INC. | $228.47 | 2019-2022 | |
| Astellas Pharma US INC | $204.31 | 2019-2024 | Veozah |
| Abbvie INC. | $179.51 | 2021-2025 | |
| Pfizer INC. | $148.46 | 2021-2025 | |
| Radius Health, INC. | $115.01 | 2019-2021 | |
| Avion Pharmaceuticals | $92.68 | 2019-2021 | |
| Daiichi Sankyo INC. | $90.94 | 2019-2020 | |
| Roche Diagnostics Corporation | $83.67 | 2019-2020 | |
| Coloplast Corp | $67.14 | 2020-2021 | |
| Coopersurgical, INC. | $54.35 | 2021-2025 | Paragard T 380a |
| Exact Sciences Corporation | $50.88 | 2025 | The Cologuard Plus Collection Kit |
| Vertical Pharmaceuticals, LLC | $43.26 | 2019 | |
| Amag Pharmaceuticals, INC. | $29.97 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $28.19 | 2025 | Gelpoint V-Path |
| Lilly USA, LLC | $28.03 | 2025 | Mounjaro, Zepbound |
| Becton, Dickinson and Company | $26.67 | 2019 | |
| Ethicon US, LLC | $24.66 | 2024 | Stratafix, Surgicel Nu-Knit, Vistaseal |
| Biogen, INC. | $23.53 | 2025 | Zurzuvae |
| Meditrina | $23.47 | 2024 | |
| Minerva Surgical, INC | $22.40 | 2025 | |
| Exeltis, USA INC. | $21.87 | 2025 | Slynd |
| Lupin INC. | $18.65 | 2020 | |
| Merck Sharp & Dohme LLC | $17.05 | 2020 | |
| Organon LLC | $16.57 | 2021 | |
| Olympus America INC. | $14.33 | 2021 | |
| Currax Pharmaceuticals LLC | $13.89 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tricia Markusen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.